ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Lipid-lowering medications in children

Lipid-lowering medications in children
Class Drug Initial daily dose Upper daily dose studied in clinical trials (children aged ≥10 years)[1] Maximum daily dose (adult) Available strengths (United States)
Statins
  Atorvastatin 5 to 10 mg 20 mg 80 mg 10, 20, 40, 80 mg
Fluvastatin 20 mg 80 mg 80 mg 20, 40 mg, 80 mg (extended release)
Lovastatin 10 mg 40 mg 80 mg

10, 20, 40 mg

20, 40, 60 mg (extended release)
Pravastatin 10 mg

40 mg (age 14 to 18 years)

20 mg (age 8 to 13 years)
80 mg 10, 20, 40, 80 mg
Rosuvastatin 5 mg 20 mg 40 mg 5, 10, 20, 40 mg
Simvastatin

10 mg (age ≥10 years)

5 mg (age 10 years)
40 mg 40 mg 5, 10, 20, 40, 80 mg
Cholesterol absorption inhibitors
  Ezetimibe 10 mg 10 mg 10 mg 10 mg
Fibric acid derivates
  Gemfibrozil 1200 mg* Data lacking 1200 mg 600 mg
Fenofibrate 40 mg Data lacking 130 to 200 mg (maximum dose depends on preparation; see Lexicomp drug reference) 40, 43, 48, 50, 54, 67, 100, 120, 134, 145, 160, 200 mg (available strengths vary by preparation; see Lexicomp drug reference)
Bile acid sequestrants
  Cholestyramine 2 to 4 g or 240 mg/kg per day

8 g

4 g (age <10 years)
16 g 4 g per packet or scoop
Colestipol 2.5 to 5 g 12 g 20 g

5 g per packet or scoop

1 g tablet
Colesevelam 1.25 g 3.75 g 3.75 g

3.75 g per packet

625 mg tablet
Omega-3 fish oils
  Omega-3 acid ethyl esters 1 g Data lacking 4 g 1 g (many strengths available)
Always review drug interactions upon initiation and alteration of treatment. Specific interactions may be determined using the drug interactions tool (Lexi-Interact Online) included with UpToDate. This tool can be accessed from the UpToDate online search page or through the individual drug information topics in the section on Drug interactions.
Children and adolescents are generally not managed with more than one class of lipid-lowering agents due to increased risk of side effects. Combinations of statins and fibrates should be administered under the supervision of a pediatric lipid specialist.
LDL-C: low-density lipoprotein cholesterol.
* An initial 600 mg daily dose of gemfibrozil may be considered. Data in children are lacking.
​ The US Food and Drug Administration has placed a black box label on simvastatin at a dose of 80 mg per day because it is associated with muscle toxicity in adults. If a daily dose of 40 mg of simvastatin is insufficient to achieve LDL-C control, a change to a more potent statin (eg, atorvastatin or rosuvastatin) is suggested. Doses of simvastatin that exceed 40 mg per day should be given under the supervision of a pediatric lipid specialist, and are generally not required, as more potent statins are available.
Reference:
  1. Data from: Daniels DR, Benuck I, Christakis DA, et al. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report-2011. National Heart Lung and Blood Institute. Available at: https://www.nhlbi.nih.gov/node/80139 (Accessed April 4, 2012).
Graphic 69650 Version 10.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟